Homepage > Arena > V-Wave

Invest in V-Wave shares

  • Category Medical Devices
  • Investment Type Private Stocks Seller
  • Year Founded 2009
  • Amount Raised For 'Accredited Investors'
  • Available Offers Up to 50 offers available

Overview

Location: Israel

Employees: 11-50

Business Model: Manufacturing / OEM, B2B

Category: Biotechnology, Health Care, Medical Device, Cardiology

Geographic Markets: Europe, North America, Israel

Company Overview:

V-Wave has developed an implantable shunt meant to treat heart failure patients by regulating left atrial pressure.

V-Wave’s team of medical scientists have designed the small shunt that can be implanted trans-venously where it shunts excess blood away from the left ventricle, a problem that leads to over 3 million hospitalizations a year. By focusing on the cause of the heart disease and not just the symptoms V-Wave is striving to create a solution that enhances the quality and length of life for patients.

V-Wave makes money by selling implantable devices for treating patients with chronic Heart Failure.


Analyst:

Need more insights?

The Due Diligence Report for V-Wave, prepared with crowd analysis and predictive algorithms, perfect for investment assessment, research and general in depth analysis.


View Report It's Free

Founders:

Yaacov Nitzan
Co-Founder
Gad Keren
Co-Founder
Ascher Shmulewitz
Co-Founder

Leading Investors:

  • BRM Group

  • Pontifax


Key Facts:

V-Wave began clinical trials in 2013 in Israel, the United States and Europe. The V-Wave shunt is currently under investigation in multiple clinical trials in North America, Europe and Israel.

A key component of V-Wave’s team are the five medical doctors on board with decades of experience in cardiology.

V-Wave’s product could potential disrupt the market by treating an increasingly widespread medical problem.


Similar Companies:

Occlutech

Occlutech, is a rapidly expanding European hi-tech company specializing in developing and manufacturing cardiac occlusion devices and other vascular implants.

Corvia Medical

Corvia Medical a medical device company, focuses on developing structural heart devices for the treatment of heart failure.



Content & Privacy:

Confidentiality: The Elephant, the online trading arena, provides a balance between the private shareholders (employees and former employees) need to protect its confidential information and the investor’s need for the transparency necessary to make an informed investment decision.

Content Sources: All the information presented above was retrieved from public sources (media, company website, data from the registrar of private shareholder, etc.).

Responsibility: The Elephant does not accept any responsibility or liability for the accuracy, content and reliability of this information.


Diversify your investments portfolio with investments that provide access to private securities and pre-IPO leading high-tech private growth companies.

The information included in this website is intended to “Accredited Investors” only, as this term is defined in the jurisdiction in which they reside (or such similar term in such jurisdictions financial regulations).

Please note that the purchase of the shares of any Target Company may be subjected to right of first refusal of other shareholders, in some cases also to approval of the Target Company’s board of directors or other transfer restrictions as may be applicable.


Got A Question? Ask Us Now:

Full Name: *

Email: *

Telephone:

Your message: